NCT03279861View on ClinicalTrials.gov

Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2019

Conditions

Congestive Heart FailureHypertension

Interventions

DRUG

Entresto

First line therapy in Entresto arm

DRUG

Valsartan

"First line therapy in usual meds arm"

Sponsors

Collaborators (1)

All Listed Sponsors

lead

University of Maryland, Baltimore

OTHER

collaborator

Medtronic

INDUSTRY

NCT03279861 - Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD | Biotech Hunter | Biotech Hunter